During this fireside chat, we welcome Innocan Pharma, ticker symbol, INNO on the Canadian Stock Exchange and INNPF on the OTC. Presenting from Innocan is Iris Bincovich, CEO. Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients’ quality of life.

This Fireside Chat was recorded during the Lytham Partners Winter 2021 Investor Conference.